Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.10 -0.18 (-0.61%)
At close: Sep 30, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) EV to FCF (2023 - 2024)

Updated

Amylyx Pharmaceuticals' (AMLX) EV to FCF was -11.67 for Q1 2024.

Analysis

Amylyx Pharmaceuticals (AMLX) EV to FCF (2023 - 2024) Analysis & Trends

Over the twelve months ended Mar 31, 2024, Amylyx Pharmaceuticals' EV to FCF came in at -81.84; for FY2023, it was 58.56.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Amylyx Pharmaceuticals 3.24 Bn 3.24 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -11.67
Dec 31, 2023 58.56
API Access

Amylyx Pharmaceuticals EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=AMLX&period=max&api_key=YOUR_API_KEY